Judge Grants Approval To $50M Settlement To End Antitrust Claims Involving EpiPen
KANSAS CITY, Kan. — A Kansas federal judge has signed off on final approval to a settlement agreement in which Pfizer Inc. agreed to pay $50 million to settle claims that...To view the full article, register now.
Already a subscriber? Click here to view full article